Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hallvard Holdaas

Showing results (41-50 of 156) with videos related to

Pageof 16
Sort By:
Clinical Transplantation|July 19, 2003
Fluvastatin reduces atherogenic lipids without any effect on native endothelial function early after kidney transplantationAnders Asberg, Hallvard Holdaas, Alan G Jardine, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 11, 2003
The risk of living kidney donationAnders Hartmann, Per Fauchald, Lars Westlie, et al.
Lancet (London, England)|October 18, 2011
Prevention of cardiovascular disease in adult recipients of kidney transplantsAlan G Jardine, Robert S Gaston, Bengt C Fellstrom, et al.
Transplantation|December 10, 2009
Morbidity and mortality in 1022 consecutive living donor nephrectomies: benefits of a living donor registryGeir Mjøen, Ole Øyen, Hallvard Holdaas, et al.
Journal of Renal Care|July 1, 2010
Cardiovascular disease in renal transplant recipientsEmily P McQuarrie, Bengt C Fellström, Hallvard Holdaas, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 24, 2010
Minimally invasive living donor nephrectomy - introduction of hand-assistanceGeir Mjøen, Hallvard Holdaas, Per Pfeffer, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 20, 2012
Model comparisons of competing risk and recurrent events for graft failure in renal transplant recipientsIngar Holme, Bengt C Fellström, Alan G Jardine, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 1, 2006
Renal transplant dysfunction--importance quantified in comparison with traditional risk factors for cardiovascular disease and mortalityInga Soveri, Hallvard Holdaas, Alan Jardine, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 23, 2003
[Is current practice concerning living donors in kidney transplantations acceptable?]Lars Westlie, Torbjørn Leivestad, Hallvard Holdaas, et al.
Journal of Nephrology|July 5, 2011
Graft loss risk in renal transplant recipients with metabolic syndrome: subgroup analyses of the ALERT trialInga Soveri, Sadollah Abedini, Hallvard Holdaas, et al.
Pageof 16

Showing results (41-50 of 156) with videos related to

Sort By:
Pageof 16
Clinical Transplantation|July 19, 2003
Fluvastatin reduces atherogenic lipids without any effect on native endothelial function early after kidney transplantationAnders Asberg, Hallvard Holdaas, Alan G Jardine, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 11, 2003
The risk of living kidney donationAnders Hartmann, Per Fauchald, Lars Westlie, et al.
Lancet (London, England)|October 18, 2011
Prevention of cardiovascular disease in adult recipients of kidney transplantsAlan G Jardine, Robert S Gaston, Bengt C Fellstrom, et al.
Transplantation|December 10, 2009
Morbidity and mortality in 1022 consecutive living donor nephrectomies: benefits of a living donor registryGeir Mjøen, Ole Øyen, Hallvard Holdaas, et al.
Journal of Renal Care|July 1, 2010
Cardiovascular disease in renal transplant recipientsEmily P McQuarrie, Bengt C Fellström, Hallvard Holdaas, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 24, 2010
Minimally invasive living donor nephrectomy - introduction of hand-assistanceGeir Mjøen, Hallvard Holdaas, Per Pfeffer, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 20, 2012
Model comparisons of competing risk and recurrent events for graft failure in renal transplant recipientsIngar Holme, Bengt C Fellström, Alan G Jardine, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 1, 2006
Renal transplant dysfunction--importance quantified in comparison with traditional risk factors for cardiovascular disease and mortalityInga Soveri, Hallvard Holdaas, Alan Jardine, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 23, 2003
[Is current practice concerning living donors in kidney transplantations acceptable?]Lars Westlie, Torbjørn Leivestad, Hallvard Holdaas, et al.
Journal of Nephrology|July 5, 2011
Graft loss risk in renal transplant recipients with metabolic syndrome: subgroup analyses of the ALERT trialInga Soveri, Sadollah Abedini, Hallvard Holdaas, et al.
Pageof 16